Skip to main content
. Author manuscript; available in PMC: 2014 Mar 12.
Published in final edited form as: AIDS. 2010 Apr 24;24(7):1025–1033. doi: 10.1097/QAD.0b013e328332d5b1

Table 1.

Characteristics of the AIDS-related non-Hodgkin lymphoma (NHL) study, Multicenter AIDS Cohort.

Characteristics post-HIV infectiona post-AIDSb

Cases
(N= 160)
Controls
(N=160)
P-value Cases
(N=90)
Controls
(N=90)
P-value

Age at NHL diagnosis, yr 41 (25–60) 39 (24–60) 0.02 40 (25–58) 39 (28–65) 0.27

Race
  White,non-Hispanic 83% 88% 0.04 81% 89% 0.40
  Black 11% 8% 11% 4%
  Others 6% 4% 8% 7%

CD4+ T-lymphocyte counts/mm3
  > 3 yr pre-NHL 387(5, 1349) 561(3, 2030) <0.0001 369(5, 1127) 397(19, 1123) 0.23
  1–3 yr pre-NHL 209(6, 1178) 522(37, 1544) <0.0001 114(6, 1178) 238(9, 1123) 0.001
  <1 yr pre-NHL 74(0, 707) 468(4, 1255) <0.0001 32(0, 691) 98(0, 1159) 0.001

Early plasma HIV-1 RNA levels, copies/mLc 5.5 (2.0, 8.4) 4.6 (1.8, 7.4) <0.0001 5.7 (2.0, 8.4) 5.4 (2.4, 8.5) 0.35
a

cases and controls matched on post-HIV infection lymphoma-free period

b

cases and controls matched on post-AIDS lymphoma-free period

c

HIV viral load at visit closest to 18 months following HIV seroconversion or entry into study

Summary statistics are presented as median (range) or percentages and P-values were derived from Kruskal-Wallis test